25.2EGP
- Active ingredient
- co-dergocrine
- Strength
- 1.5 mg
- Form
- tablet
- Manufacturer
- novartis
- Route
- oral.solid
Uses
Used in some countries for age-related cognitive impairment and symptoms associated with cerebrovascular insufficiency.
Do not use if
Hypersensitivity to ergot derivatives or any component of the formulation.
Side effects
May cause nausea, dizziness, headache, hypotension, or gastrointestinal discomfort.
Warnings
Use cautiously in patients with cardiovascular disease or hypotension.
How it works
Mixture of hydrogenated ergot alkaloids with effects on cerebral blood flow and neurotransmitter activity.
Storage
Store at room temperature.